VIDA

About:

VIDA is modernizing lung and respiratory care through intelligence

Website: https://vidalung.ai

Twitter/X: vidalung

Top Investors: First Analysis, Blue Heron Capital, OSF Ventures, Rittenhouse Ventures, Next Level Ventures

Description:

VIDA modernizes lung and respiratory care, empowering healthcare organizations and physicians to improve patient outcomes, streamline care coordination and drive efficiencies through a comprehensive approach, proven quality, and clinical leadership. Through quantitative data intelligence and impactful visualizations, VIDA helps physicians manage patients with or at risk of chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and now, COVID-19. VIDA’s software is FDA cleared, CE-marked, Health Canada licensed and TGA registered for clinical use in the US, European Economic Area, Canada, and Australia. Learn more at vidalung.ai.

Total Funding Amount:

$33.2M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Coralville, Iowa, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)vidalung.ai

Founders:

Eric A. Hoffman, Joseph M. Reinhardt

Number of Employees:

51-100

Last Funding Date:

2023-09-29

IPO Status:

Private

© 2024 MyAiNote.com